ライフサイエンスコーパス: will be necessary to

1 lear, and it is likely that additional congressional action will be necessary to stabilize health care markets.

2 is fundamental to management and conservation efforts, and will be necessary to ensure future plans and adaptation strat

3 Screening with high uptake will expedite reductions and will be necessary to eliminate cervical cancer in countries w

4 and capacity building (data resources and researcher base), will be necessary to take full advantage of future opportunit

5 isons of Drosophila larval yeast associations more broadly, will be necessary to understand patterns of microbial resourc

6 the mechanisms underlying cortical dysmaturation due to CHD will be necessary to identify strategies for neonatal neuropr

7 , studies integrating biological information with detection will be necessary to comprehensively understand the impact of

8 Continued vigilance and anti-poaching efforts will be necessary to combat poaching and to conserve African

9 Trial continuation and additional randomised evidence will be necessary to establish the supposed superior efficacy

10 the development and persistence of chronic critical illness will be necessary to improve long-term outcomes after sepsis.

11 age or serving as a carbon source for the chemical industry-will be necessary to identify the optimal separation material

12 Prospective clinical trials with c-Met inhibitors will be necessary to validate MET exon 14 mutations as an imp

13 hophysiological processes contribute to the disease, and it will be necessary to understand this heterogeneity to find ef

14 to become useful materials for biomedical applications, it will be necessary to evaluate their biodistribution for healt

15 As more RGENs become available, it will be necessary to refine their activity before they can be

16 To achieve these benefits, it will be necessary to reduce CO2 sourcing and transport burden

17 To prove causation, it will be necessary to decipher which specific taxa or metaboli

18 In particular, it will be necessary to identify the most suitable biomarkers to

19 To identify HSCs from in vitro sources, it will be necessary to refine markers of HSCs matured ex vivo.

20 It is clear that it will be necessary to gather this information from disease rel

21 Thus, it will be necessary to develop robust, reliable, and model-base

22 l properties, and a more nuanced understanding of the mAChR will be necessary to best translate preclinical findings into

23 hing tactics, suggesting that targeting adaptive mechanisms will be necessary to mitigate BM invasion in human pathologie

24 Further validation in cell culture and mouse models will be necessary to establish causality for these genes.

25 Real-time genetic monitoring will be necessary to identify potential hybrids and support a

26 Collectively, these data suggest that multiple mutations will be necessary to fully escape eCD4-Ig without loss of vir

27 further development, including incorporation of ontologies, will be necessary to improve the performance of the extractio

28 utilitarianism and common-sense morality, and new paradigms will be necessary to investigate other key aspects of utilita

29 conditions, we find that 6-17% improvement in water quality will be necessary to bring recovery rates in line with projec

30 More research will be necessary to clarify the effects and safety of CPIs o

31 nd allow immune recognition and clearance of this reservoir will be necessary to eradicate HIV-1 in infected individuals.

32 effects of land cover across a continuum of spatial scales will be necessary to guide management decisions.

33 urrent proteomic methods used to characterize the secretome will be necessary to provide further insight into stem cells

34 ted, context-specific combination implementation strategies will be necessary to meet the newly established national targ

35 evolution of CAR designs beyond the conventional structures will be necessary to address these limitations and to expand

36 Additional studies will be necessary to characterize the predictors of cognitive

37 normalize pH and carbon dioxide levels, but further studies will be necessary to demonstrate benefit with this technology

38 Further studies will be necessary to determine which patients may benefit fro

39 Further studies will be necessary to identify its receptors, reveal its physi

40 vidual SIM-SUMO complexes and suggests that further studies will be necessary to understand these interactions when occur

41 Longitudinal follow-up studies will be necessary to ascertain the long-term neurological and

42 Specific validation studies will be necessary to determine the best combination of imagin

43 Continued genomic surveillance will be necessary to accurately assess how the population of

44 roperties, but also their surrounding surface topographies, will be necessary to improve the yield of single quantum dot

45 A clinical trial will be necessary to validate the usefulness of this approach

46 Longer-term follow-up of randomized clinical trials will be necessary to confirm these findings.

47 Longer follow-up will be necessary to fully evaluate treatment differences.

48 Additional data and longer follow-up will be necessary to gain insight into these issues.

49 Further work will be necessary to integrate other metals, and IL-1 into th

50 sistence, especially for younger and substance-using YBMSM, will be necessary to achieve full PrEP effectiveness.